M Masi

778 citations
26 papers · 597 indexed · h-index 13

M Masi

26 papers receiving 583 citations

Peers

M Masi
Comparison fields: 5 of 54
  • Hematology 458
  • Genetics 105
  • Rheumatology 89
  • Oncology 129
  • Public Health, Environmental and Occupational Health 130
Replace D. Urbanitz with:
D. Urbanitz Germany
Ali Tabarroki United States
Salvatore Palmieri Italy
A Granda Spain
Angeline Van Orshoven Belgium
Jolanta B. Perz Germany
Martine Guesnu France
J Sans-Sabrafén Spain
Naoko Hosono Japan
Hyeoung Joon Kim South Korea
M Masi relative to D. Urbanitz Germany D. Urbanitz's profile →
Citations per field
00.5×
D. Urbanitz · 1×
Citations per year

Countries citing papers authored by M Masi

Since Specialization
Citations

This map shows the geographic impact of M Masi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Masi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Masi more than expected).

Fields of papers citing papers by M Masi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Masi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Masi. The network helps show where M Masi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside M Masi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M Masi Line = papers co-authored together M Masi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2
Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies.
200418
3 200024
4 199815
5 199622
6 199621
7 19966
8 1996113
9
All-trans retinoic acid and low-dose cytosine arabinoside for the treatment of 'poor prognosis' acute myeloid leukemia.
199542
10 199467
11
[The use of thymopentin in the prevention of recurrent infections of the respiratory system. Multicenter study].
19933
12 19934
13 19937
14
Cytotoxic effects of dacarbazine in patients with acute myelogenous leukemia: a pilot study.
199218
15
Ascorbic acid as first-line therapy in immune thrombocytopenic purpura.
19921
16
Anti-D treatment in thrombocytopenia refractory to conventional therapies.
19922
17
Mitoxantrone in combination with etoposide and cytarabine for treatment of poor prognosis acute non lymphoid leukemia patients.
19922
18
The plicamycin and hydroxyurea combination chemotherapy for chronic granulocytic leukemia in myeloid transformation.
19911
19
Peripheral polyneuropathy during treatment with alpha-2 interferon.
199112
20
Effects of asphyxia and oral gentamicin on intestinal lactase in the suckling rat.
19813

About M Masi

M Masi is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 26 papers that have together received 597 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (15 papers), Chronic Myeloid Leukemia Treatments (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Retinoids in leukemia and cellular processes (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Autoimmune Bullous Skin Diseases (3 papers), Neutropenia and Cancer Infections (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). The work is most often cited by research in Hematology (458 citations), Genetics (105 citations) and Rheumatology (89 citations). M Masi has collaborated with scholars based in Italy. Frequent co-authors include Roberto Stasi, Giovanni Del Poeta, Adriano Venditti, Antonio Bruno, Germano Aronica, Maria Christina Cox, M Tribalto, Sergio Amadori, Francesco Buccisano and Elisa Stipa. Their work appears in journals such as Blood, Annals of Hematology, Animals and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026